Current 94.3
    • Homepage
Knight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity

Author: Knight Therapeutics

Posted Date:

March 27, 2026
  • Knight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity

    Knight Therapeutics
    March 27, 2026
  • Knight Amends Normal Course Issuer Bid

    Knight Therapeutics
    March 23, 2026
  • Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results

    Knight Therapeutics
    March 19, 2026
  • Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Argentina and Mexico

    Knight Therapeutics
    March 17, 2026
  • Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil

    Knight Therapeutics
    March 17, 2026
  • Notice of Knight Therapeutics’ Fourth Quarter and Year End 2025 Results Conference Call

    Knight Therapeutics
    March 12, 2026
  • Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil

    Knight Therapeutics
    February 18, 2026